LEASY TO LEARN NOTES WITHOUT MISSING ANY POINTS EXCEPT MEDICINE DOSES

Reading File
Running Command
Running Command
Running Command
I now have all the content from the PDF. Let me create comprehensive, easy-to-learn notes.

πŸ“‹ HAIR DISEASES - EASY STUDY NOTES

(Chapter 24 - Habif's Clinical Dermatology)


πŸ”¬ ANATOMY & PHYSIOLOGY

Types of Hair

TypeDescription
Terminal hairThick, pigmented - scalp, beard, axilla, pubic area - androgen-dependent
Vellus hairShort, fine, non-pigmented "peach fuzz" - androgen-independent
Lanugo hairFine hair on fetus

Hair Follicle Sections (Top to Bottom)

  1. Infundibulum - surface to sebaceous gland duct
  2. Isthmus - from sebaceous duct to erector pili muscle insertion
  3. Inferior segment - exists only during anagen; from muscle to matrix

Hair Shaft Layers (outer β†’ inner)

  • Cuticle (outermost - protects cortex)
  • Cortex (bulk of shaft - contains pigment melanosomes)
  • Medulla (innermost - sometimes absent)

Key Facts

  • Humans have ~5 million follicles at birth; NO new follicles form after birth
  • Scalp has >100,000 hairs
  • Scalp hair grows 0.3-0.4 mm/day (β‰ˆ6 inches/year)
  • The bulge (outer root sheath near arrector pili) = stem cell reservoir for follicle regeneration

Hair Growth Cycle

ANAGEN (growing) β†’ CATAGEN (transitional) β†’ TELOGEN (resting) β†’ ANAGEN
    2-6 years           2-3 weeks              2-3 months
    90-95%               <1%                    5-10%
PhaseKey Features
AnagenActive growth; matrix cells divide rapidly; hair pigmented
CatagenInvolution; cell death; club hair forms; hair ascends to erector level
TelogenResting; club hair (white, solid, dry bulb) held then shed; 25-100 hairs shed/day
Club hair = dead hair; solid white proximal end; shed during telogen

πŸ” EVALUATION OF HAIR LOSS

Systematic Approach (Box 24.1)

History Questions

  • Sudden vs gradual
  • Systemic disease or fever
  • Recent stress (physical/psychological)
  • Medications/chemicals

Examination

  • Localized vs generalized
  • Scarring vs non-scarring
  • Inflammatory vs non-inflammatory
  • Follicular plugging

Diagnostic Tools

TestHowNormal Result
Hair pull testGrasp 20-40 hairs 3 cm above auricle; slow traction< 6 club hairs
Daily countsCollect hairs for 14 days in morning combing + wash< 100/day; < 200 on shampoo days
Part widthCoronal parts over vertex - compare part diameter-
Hair pluck (trichogram)Abruptly extract hairs; examine bulbs-
TrichoscopyDermoscope - follicular ostia, shafts, vessels-
Hair growth windowShave 2 cmΒ² area, occlude 1 week; check regrowth2.5 mm/week

Anagen vs Telogen Hair (Microscopy)

Anagen HairTelogen Hair
BulbElongated, pigmented, broom-shapedSmall, unpigmented, ovoid
SheathGelatinous sheath presentNo sheath

πŸ“Š SIMPLIFIED DIAGNOSIS TABLE (97% of cases)

DiseasePatternPull TestTreatment
Telogen effluviumDiffuse+ telogenDisease-specific
Diffuse AAIrregularly diffuse+ telogenTopical immunotherapy
AGA (men)Hamilton patternNegativeMinoxidil, Finasteride, Surgery
AGA (women)Ludwig patternNegativeMinoxidil, Spironolactone
Discoid lupusPatchy, scarring, dyspigmentationNegativeIntralesional steroids, Hydroxychloroquine
Lichen planopilarisPatchy, scarringNegativeIntralesional steroids, Hydroxychloroquine
Frontal fibrosingFrontal hairline recessionNegativeSame as LPP
Alopecia areataPatchy, exclamation mark hairsMaybe + at marginsIntralesional steroids, Minoxidil
Tinea capitisPatchy, scale/pustulesHair breakage (KOH+)Oral antifungal
TrichotillomaniaPatchy with stubbleUsually negativeFluoxetine, psychotherapy
Traction alopeciaPatchy, marginalHair breakageAvoid traction
SyphilisMoth-eaten+ telogenPenicillin

🌊 GENERALIZED HAIR LOSS

1. Telogen Effluvium (TE)

Mechanism: Premature termination of anagen β†’ excess follicles enter telogen β†’ massive shedding ~3 months later
Key Features:
  • Normal scalp, diffuse loss, NO scarring
  • Up to 50% hair affected
  • Resting hairs shed ~100 days after trigger
Types:
Acute TEChronic TE (CTE)
Duration<6 months>8 months (up to 7 years)
Onset1-3 months post-eventAbrupt, fluctuating
PatternDiffuseDiffuse + bitemporal recession
WhoAny30-60 yr old women
Pull test>4 hairs2-8 hairs
Common Triggers for TE:
  • High fever
  • Severe emotional/physical trauma
  • Postpartum (1-4 months after delivery - delayed anagen release)
  • Drugs (see below)
  • Hypothyroidism, iron deficiency
  • Crash diets
Drugs Causing Telogen Effluvium: Acitretin, amphetamines, captopril, carbamazepine, coumadin, lithium, propranolol, valproic acid, heparin, retinoids, anticoagulants, anticonvulsants, antithyroids, beta-blockers, amiodarone, penicillamine

2. Anagen Effluvium

FeatureTelogen EffluviumAnagen Effluvium
Onset2-4 months after insult1-4 weeks after insult
Hair loss %20-50%80-90%
Hair type lostClub hair (white bulb)Anagen hair (pigmented bulb)
ShaftNormalNarrowed or fractured
CauseStress, postpartum, drugsChemotherapy, radiation
Mechanism: Direct insult to matrix cells β†’ hair shaft narrowing β†’ breakage; 90% of hairs affected (all in anagen)
  • Scalp hypothermia (DigniCap, Paxman) can minimize chemotherapy-induced loss

3. Loose Anagen Hair Syndrome (LAS)

  • Children; female:male = 6:1
  • Defective anchorage of hair shaft β†’ easily, painlessly pluckable hair
  • Young girl with short blond hair that won't grow long
  • Pull test: >10 loose anagen hairs (normal = 1-2)
  • Trichogram: β‰₯70% loose anagen, no telogen
  • Most improve with age

🎯 LOCALIZED HAIR LOSS

Androgenetic Alopecia (AGA) - Men (Male Pattern Baldness)

Key Points:
  • Physiologic reaction; polygenic inheritance
  • Begins age 12-40; ~50% express before age 50
  • Androgen-sensitive follicles on top; androgen-independent on sides/back
Hamilton Pattern Classification:
Type I    = Normal (minimal frontotemporal recession)
Type II   = Slight frontotemporal recession
Type III  = Deep frontotemporal + midfrontal recession
III vertex= Hair loss on vertex
IV-VII    = Progressively increasing vertex + frontal baldness
Pathophysiology:
  • Testosterone (T) β†’ DHT via 5Ξ±-reductase type II (in hair follicles + prostate)
  • DHT binds follicle androgen receptor β†’ miniaturizes follicles
  • Terminal hairs β†’ vellus hairs; anagen shortens progressively
  • Inflammation around bulge area damages stem cells

Female Pattern Hair Loss (AGA in Women)

Key Features:
  • Ludwig pattern: Central scalp thinning; frontal hairline PRESERVED (key difference from men)
  • Widening of central hair part
  • "Pony tail is thinner"
  • Pull test normal; miniaturized hairs of varying diameter
  • More common with PCOS and other androgen excess states
Laboratory Workup:
ParameterFemale AGAFemale AGA + HirsutismMale Pattern (Frontotemporal)
DHEA-SNormal or elevatedNormal/elevatedElevated
TestosteroneNormalNormal/elevatedElevated
TeBGNormalDecreased/normalDecreased/normal

πŸ§” HIRSUTISM

Definition: Excessive terminal hair in a MALE pattern in women
Affects: 5-10% of women

Ferriman-Gallwey (mFG) Scoring

  • 9 body sites (upper lip, chin, chest, upper/lower back, upper/lower abdomen, arm, thigh)
  • Score 0-4 per site
  • Score 6-8 = hirsutism in white/black women
  • <5% of reproductive-age women score >7

Etiology (Box 24.4)

CauseFrequency
PCOSMost common (>80%)
Idiopathic hirsutism~10% (normal androgens, normal ovulation)
Nonclassic congenital adrenal hyperplasia~2%
Androgen-secreting tumor0.2% (50% malignant)
Cushing syndromeRare
HyperprolactinemiaRare

Virilization = Hirsutism PLUS:

  • Clitoral hypertrophy
  • Deepening voice
  • Temporal balding
  • Decreased breast size
  • Amenorrhea
  • Increased muscle mass
  • Acne + increased sebum β†’ Suggests ovarian or adrenal tumor

Polycystic Ovary Syndrome (PCOS)

Diagnosis: Any 2 of 3:
  1. Oligomenorrhea/anovulation
  2. Clinical/biochemical hyperandrogenism (hirsutism, acne, elevated T)
  3. Polycystic ovaries on ultrasound (>8 follicles/ovary, all <10mm) (After excluding: congenital adrenal hyperplasia, Cushing, androgen-secreting tumor, acromegaly)
Features:
  • 6% of reproductive-age women
  • Insulin resistance + hyperinsulinemia
  • Elevated LH, T; reduced SHBG
  • Obesity in 70%
  • 3Γ— increased risk of endometrial cancer
  • Risk of type 2 DM (up to 40%)
  • Impaired glucose tolerance in up to 40%

Alarm Values (Tumor Workup):

  • Total T > 6.9 nmol/L (>200 ng/dL)
  • DHEA-S > 18.9 nmol/L (>7000 ng/mL) β†’ Suggests ovarian or adrenal androgen-producing tumor

Hirsutism Treatment Principles

  • First-line: Oral contraceptives (suppress LH β†’ ↓ ovarian androgens; ↑ SHBG β†’ ↓ free androgen)
  • Add antiandrogen after 6 months if poor response
  • At least 6 months of treatment needed for response
  • Cosmetic: shaving, waxing, eflornithine cream (Vaniqa), laser/IPL
Antiandrogens: Spironolactone, cyproterone acetate, finasteride, flutamide
  • All equally effective
  • Teratogenic β†’ always use with contraception
Eflornithine (Vaniqa):
  • Irreversible inhibitor of ornithine decarboxylase
  • Slows hair growth (not permanent)
  • Results in 6-8 weeks; regrows when stopped
Photoepilation (Laser/IPL) Selection:
Skin/HairDevice
Light skin/dark hairShort wavelength laser
Dark skin/dark hairLong wavelength or IPL
Light/white hairIPL + radiofrequency

πŸ”΅ ALOPECIA AREATA (AA)

Definition: Common autoimmune disease; rapid onset total hair loss in sharply defined, round areas
Types:
  • AA = Patchy scalp hair loss
  • Alopecia totalis = 100% scalp hair loss
  • Alopecia universalis = 100% loss of scalp + body hair
  • Ophiasis pattern = Band-like loss in parietotemporo-occipital area (poor prognosis)
Prevalence: 0.1-0.2% of US population; 60% present before age 20

Clinical Features

  • Smooth, white/normal scalp
  • "Exclamation point" hairs - normal upper shaft, narrowed base - at periphery of patch
  • Regrowth in 1-3 months; may be white/fine initially
  • Eyelashes + beard are second most common sites

Nail Changes (10-66%):

  • Pitting (irregular, organized rows, or longitudinal)
  • "Sandpaper nails" appearance

Prognosis

  • Majority regrow within 1 year without treatment
  • 10% develop chronic disease and may never regrow
  • Poor prognosis: family history AA, young age, nail dystrophy, atopy, extensive loss, immune diseases

Pathology

  • "Swarm of bees" = peribulbar lymphocytic infiltrate
  • NO scarring
  • Inflammation terminates anagen β†’ catagen
  • Bulge SPARED β†’ new hair can regrow after inflammation resolves

Etiology

  • Unknown; autoimmune T-lymphocyte mediated
  • Associations: thyroid disease (8-11.8%), vitiligo (4Γ— increased), atopy (2Γ—)

Differential Diagnosis

  • Tinea capitis (KOH+, scale)
  • Trichotillomania (irregular, broken hairs, not completely bald)
  • Secondary syphilis (moth-eaten pattern)
  • Telogen effluvium (diffuse, not patchy)

AA Treatment by Age & Severity

Children < 10 years:
  • Topical midpotent corticosteroid + 5% minoxidil solution
  • Alternative: Anthralin (short contact)
Adults β‰₯ 10 years, <50% scalp:
  • Intralesional corticosteroids (triamcinolone acetonide 5-10 mg/mL)
    • Regrowth in 4-8 weeks; 60-67% response rate; repeat every 4-6 weeks
  • Β± 5% topical minoxidil twice daily
  • Β± Topical corticosteroid
Adults β‰₯ 10 years, >50% scalp:
  • 5% topical minoxidil + topical corticosteroid
  • Topical immunotherapy (DPCP) - treatment of choice for >50% scalp in adults
  • Anthralin (20-25% response)
  • Oral corticosteroids (rarely; high relapse rate)
Topical Immunotherapy (DPCP):
  • Diphenylcyclopropenone - first choice for >50% scalp
  • Squaric acid dibutyl ester (SADBE) - alternative
  • ~60% success rate in experienced hands
  • Goal: mild itching, erythema, scaling

🧠 TRICHOTILLOMANIA (TTM)

Definition: Chronic impulse control disorder (or OCD-spectrum); repetitive hair-pulling β†’ alopecia
Prevalence: 0.6-13%; average onset age 11-13 years; female:male = 2.5:1

DSM-5 Diagnostic Criteria (Box 24.11)

  1. Hair loss from recurrent hair-pulling
  2. Repeated attempts to stop
  3. Significant distress/impairment
  4. Not due to dermatologic condition
  5. Not better explained by another mental disorder

Clinical Features

  • Frontoparietal scalp most common (easily reached)
  • Irregular, angulated border
  • Area is NEVER completely bald (unlike AA)
  • Short, broken hairs of varying lengths randomly distributed
  • Eyebrows and eyelashes may be involved

Diagnosis

  • Ask patient directly about hair manipulation
  • No telogen hairs on pull test (nearly 100% anagen)
  • Biopsy: normal hairs, absent hairs in follicles, NO leukocyte infiltration; catagen hairs in 74%
  • Hair growth window test: cover shaved area for 1 week β†’ normal growth proves hair is growing

Difference from AA:

TTMAlopecia Areata
Bald patchesNever completely baldCompletely devoid
HairShort, brokenAbsent; exclamation point hairs
Pull testNegative (all anagen)Positive at margins
BiopsyCatagen hairs, pigment castsSwarm of bees infiltrate

Treatment

  • Supportive counseling (physician/parent)
  • Habit reversal therapy (superior to pharmacotherapy)
  • Clomipramine (more effective than placebo; SSRIs = NOT proven superior to placebo)
  • Consider psychiatric referral for extensive cases

➑️ TRACTION ALOPECIA

  • Caused by: braids, ponytails, rollers, hot straightening combs
  • Hair loss corresponds exactly to the stressed area
  • Usually temporary; rarely permanent
  • Treatment: Avoid the causative hairstyle

πŸ”₯ SCARRING ALOPECIAS

Key principle: Permanent hair loss because follicle is DESTROYED (unlike non-scarring)

Primary vs Secondary Scarring Alopecia

PrimarySecondary
TargetFollicle is the targetFollicle destroyed by non-follicular process
End stageSmooth skin, no follicular orificesSame
Primary - Lymphocytic: DLE, LPP, Frontal fibrosing, Pseudopelade, CCCA Primary - Neutrophilic: Folliculitis decalvans, Dissecting cellulitis Primary - Mixed: Acne keloid, Tufted folliculitis, Acne necrotica, Erosive pustular dermatosis

1. Central Centrifugal Cicatricial Alopecia (CCCA)

(formerly: Hot Comb Alopecia, Follicular Degeneration Syndrome)
  • Most common cicatricial alopecia in black women
  • Starts at vertex, spreads forward/outward
  • Early stage: erythema, scaling around follicles; pruritus, scalp tenderness
  • Late stage: scarring, fibrosis
  • Association with type 2 diabetes mellitus
  • Treatment: topical/intralesional corticosteroids, topical minoxidil; doxycycline for inflammatory disease

2. Chronic Cutaneous Lupus Erythematosus (Discoid LE)

  • Common cause of scarring alopecia
  • More common in women
  • Classic lesion: "carpet tack scale" (follicular plugging with scale attached to underside)
  • Well-circumscribed, erythematous, scaly plaques β†’ atrophic hypopigmented/hyperpigmented scars
  • Immunofluorescence: IgG, IgM deposits at dermoepidermal junction
  • Treatment: Topical/intralesional corticosteroids, hydroxychloroquine, oral agents (azathioprine, cyclosporine)

3. Lichen Planopilaris (LPP)

  • More common in adult women
  • Lesions: centrifugal pattern, vertex-centered
  • Spinous, hyperkeratotic follicular papules with perifollicular erythema
  • Smooth, atrophic, polygonal-shaped patches; scarring central, active at margins
  • Patients: pain, stinging, burning
  • Immunofluorescence: cytoid body staining (IgM, IgA) - positive in 50%
  • Differential: DLE, pseudopelade, folliculitis decalvans
  • Treatment: Superpotent topical steroids, intralesional steroids, short oral steroids; hydroxychloroquine; doxycycline, tetracycline, cyclosporine

4. Frontal Fibrosing Alopecia (FFA)

  • Variant of LPP
  • Mainly postmenopausal women
  • Scarring from frontal hairline extending backward
  • Perifollicular erythema + minute perifollicular papules at advancing edge
  • Eyebrow loss common
  • Biopsy = same as LPP
  • Poor prognosis for recovery

5. Pseudopelade (of Brocq)

  • Rare, slowly progressive, non-inflammatory scarring alopecia
  • "Footprints in the snow" appearance - skin-colored, slightly depressed patches
  • Starts on crown; moth-eaten-like patches coalesce
  • May be end-stage of other scarring alopecias
  • Treatment resistant to topicals; intradermal steroids

6. Folliculitis Decalvans

  • Chronic pustular eruption β†’ patchy permanent alopecia
  • Crops of pustules surrounding multiple expanding oval areas of alopecia
  • Staphylococcus aureus cultured from pustules
  • Biopsy: follicular neutrophilic abscesses (early); dermal lymphocytes + scarring (late)
  • Treatment: Culture pustules; antibiotics (rifampicin + clindamycin Γ— 10 weeks; dapsone); topical mupirocin

7. Dissecting Cellulitis

  • Young black men
  • Boggy, fluctuant scalp nodules on crown/vertex/occiput
  • Interconnected abscesses with sinus tracts β†’ extensive scarring
  • Part of "follicular occlusion triad" (dissecting folliculitis + hidradenitis suppurativa + acne conglobata)
  • Treatment: Antibiotics; isotretinoin; adalimumab (reported effective)

8. Acne Keloidalis Nuchae

  • Young black men (much less common in white men)
  • Occipital scalp and posterior neck
  • Follicular papules/pustules β†’ fibrosis β†’ firm keloidal papules
  • Initially neutrophilic inflammation
  • Treatment: Antibiotics (topical and oral); topical/intralesional steroids; surgery in advanced cases

9. Tufted Folliculitis

  • End stage of other scarring alopecias (folliculitis decalvans, acne keloidalis, etc.)
  • Multiple hairs (2-10+) emerging from single dilated follicular orifice
  • Follicular rupture + abscess + fibrosis around follicles
  • Treatment: Same as folliculitis decalvans

10. Acne Necrotica

  • Severe scalp folliculitis
  • Papules/pustules β†’ crusts β†’ depressed scars
  • Can also affect face
  • Treatment: Minocycline, topical clobetasol

11. Erosive Pustular Dermatosis

  • Elderly; actinically damaged scalp
  • Often follows trauma or destructive treatment
  • Red, pustular, crusted, eroded plaques
  • Progressive scarring alopecia
  • Biopsy: lymphocytes and plasma cells in dermis
  • Treatment: Potent topical steroids, tacrolimus, calcipotriol, acitretin, isotretinoin, topical dapsone gel

🦠 TRICHOMYCOSIS

  • Asymptomatic infection of axillary or pubic hair by Corynebacterium
  • Hair shaft coated with adherent yellow (occasionally red or black) firm concretions
  • Associated with hyperhidrosis
  • Treatment: Shave hair; control hyperhidrosis with antiperspirants; Naftifine 1% cream

πŸ₯ QUICK COMPARISON CHART: KEY DISEASES

DiseasePopulationPatternScarringKey Feature1st Line Rx
Telogen effluviumAnyDiffuseNoPositive pull test; trigger 3 mo priorRemove trigger
Anagen effluviumPost-chemoDiffuseNo80-90% loss; 1-4 weeksStop offending agent
Male AGAMenHamiltonNoDHT-mediated; vertex + frontalMinoxidil/Finasteride
Female AGAWomenLudwigNoFrontal hairline preservedMinoxidil
Alopecia areataAny, youngPatchy roundNoExclamation mark hairs; "swarm of bees"Intralesional steroids
TrichotillomaniaChildren/teensIrregular patchyNoNever bald; broken hairs; all anagenHabit reversal
Tinea capitisChildrenPatchyNoScale/KOH positiveOral antifungal
DLEWomenPatchyYesCarpet tack scale; dyspigmentationHydroxychloroquine
LPPAdult womenPatchy, vertexYesPerifollicular erythema/papulesTopical/IL steroids
FFAPostmenopausal womenFrontal recessionYesFrontal hairline recedes backwardSame as LPP
CCCABlack womenVertex spreadingYesStarts vertex; DM associationIL triamcinolone
Folliculitis decalvansAdultsPatchyYesPeripheral pustules; Staph. aureusRifampicin + clindamycin
Dissecting cellulitisYoung black menCrown/vertexYesBoggy abscesses, sinus tractsAntibiotics/isotretinoin
Acne keloidalisYoung black menOccipitalYesKeloidal papules on napeAntibiotics + steroids
TrichomycosisAnyAxillary/pubicN/AYellow concretions on shaftShave + antiperspirant

πŸ§ͺ ANDROGEN METABOLISM SUMMARY

Testosterone (T)
        ↓  [5Ξ±-reductase Type I: sebaceous glands]
        ↓  [5Ξ±-reductase Type II: hair follicles, prostate]
       DHT (Dihydrotestosterone)
        ↓
Androgen receptor in dermal papilla
        ↓
- Scalp: miniaturizes follicles β†’ AGA
- Beard/chest/pubic: enlarges follicles β†’ terminal hair growth
Finasteride blocks 5Ξ±-reductase Type II Dutasteride blocks both Type I and Type II

⚠️ HIGH-YIELD POINTS FOR EXAMS

  1. Telogen effluvium occurs ~3 months after the trigger
  2. Postpartum hair loss = delayed anagen release (1-4 months post-delivery)
  3. Exclamation point hairs = pathognomonic of alopecia areata
  4. "Swarm of bees" peribulbar infiltrate = alopecia areata (no scarring)
  5. "Carpet tack scale" = Discoid lupus erythematosus
  6. "Footprints in the snow" = Pseudopelade
  7. Tufted folliculitis = multiple hairs from single orifice
  8. Follicular occlusion triad = dissecting folliculitis + hidradenitis suppurativa + acne conglobata
  9. CCCA is most common cicatricial alopecia in black women
  10. Dissecting cellulitis + acne keloidalis = young black men
  11. Anagen hairs = all affected in trichotillomania (no telogen on pull test)
  12. Hamilton classification = male AGA; Ludwig classification = female AGA
  13. Ophiasis pattern AA = poor prognosis
  14. AA prognosis: >1 year disease, alopecia totalis, nail dystrophy, atopy = poor outcome
  15. PCOS diagnosis requires 2 of 3: oligomenorrhea, hyperandrogenism, polycystic ovaries
  16. Ferriman-Gallwey score β‰₯ 6-8 = hirsutism
  17. 5Ξ±-reductase absent congenitally β†’ AGA does NOT develop (confirms DHT role)
  18. Finasteride NOT effective in postmenopausal women with AGA
  19. Habit reversal therapy > pharmacotherapy for trichotillomania
  20. Trichomycosis = Corynebacterium (NOT fungi, despite the name)

Source: Chapter 24, Habif's Clinical Dermatology
This is a shared conversation. Sign in to Orris to start your own chat.